MSF Field Research > 1 Published Research and Commentary > TB > Linezolid for multidrug-resistant tuberculosis.

Please use this identifier to cite or link to this item: http://hdl.handle.net/10144/269593
    Del.icio.us     LinkedIn     Citeulike     Connotea     Facebook     Stumble it!

Download this article: View/Open File Description Size Format View/Open Cox H et al Linezolid for multidrug-resistant - Lancet ID 13-01 2013-01.pdf 40Kb Adobe PDF

Related articles on PubMed

Linezolid for multidrug-resistant tuberculosis. Chang KC, Leung CC, Daley CL 2012 Jul

Linezolid for multidrug-resistant tuberculosis - authors' reply. Chang KC, Leung CC, Daley CL 2013 Jan

Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis. Yew WW, Chang KC, Chau CH 2009 Nov

Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis--authors' response. Koh WJ, Shim TS 2009 Nov

Linezolid-containing regimens for the treatment of drug-resistant tuberculosis in South African children. Rose PC, Hallbauer UM, Seddon JA, Hesseling AC, Schaaf HS 2012 Dec

See all 101 articles

All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.